PT  - JOURNAL ARTICLE
ED - BMJ Publishing Group Ltd
TI  - Post-exposure prophylaxis for HIV
AID  - 10.1136/dtb.2011.02.0016
DP  - 2011 Mar 01
TA  - Drug and Therapeutics Bulletin
PG  - 30--33
VI  - 49
IP  - 3
4099  - http://dtb.bmj.com/content/49/3/30.short
4100  - http://dtb.bmj.com/content/49/3/30.full
SO  - Drug Ther Bull2011 Mar 01; 49
AB  - Relevant BNF section: BNF 5.3.1 Definite or suspected occupational exposure of healthcare workers to human immunodeficiency virus (HIV) infection is a medical emergency.1 Post-exposure prophylaxis (PEP) with antiretroviral drugs is widely available following such exposure, aiming to prevent HIV infection.1 PEP following non-occupational exposure (nPEP) is also increasingly being provided.2 The term PEPSE (PEP following sexual exposure) is also commonly used, recognising that most non-occupational exposure is sexual.3 Here we discuss the evidence supporting the use of PEP and nPEP and advice in current guidelines.